Article

European Journal of Human Genetics (2007) 15, 843–847; doi:10.1038/sj.ejhg.5201847; published online 2 May 2007

Spectrum of CREBBP gene dosage anomalies in Rubinstein–Taybi Syndrome patients

Marianne Stef1,5, Delphine Simon1,5, Béatrice Mardirossian1, Marie-Ange Delrue1,2, Ingrid Burgelin1, Christophe Hubert1,3, Michèle Marche1, Françoise Bonnet1,4, Philippe Gorry1,2, Michel Longy1,4, Didier Lacombe1,2, Isabelle Coupry1 and Benoît Arveiler1,2,3

  1. 1Laboratoire de Génétique Humaine, Développement et Cancer (EA 3669), Université Victor Segalen Bordeaux 2, Bordeaux, France
  2. 2Service de Génétique Médicale, CHU de Bordeaux, Bordeaux, France
  3. 3Pôle Génotypage-Séquençage de Bordeaux, Bordeaux, France
  4. 4Institut Bergonié, Bordeaux, France

Correspondence: Professor B Arveiler, Laboratoire de Génétique Humaine, Développement et Cancer (EA3669), Université Victor Segalen Bordeaux 2, 146 Rue Léo Saignat, 33076 Bordeaux, France. Tel: +33 5 57 57 11 63; Fax: +33 5 56 98 33 48; E-mail: benoit.arveiler@u-bordeaux2.fr

5These authors contributed equally to the work

Received 27 November 2006; Revised 17 March 2007; Accepted 4 April 2007; Published online 2 May 2007.

Top

Abstract

The Rubinstein–Taybi syndrome (RTS) is a rare autosomal-dominant disease associated with 10–15% of cases with 16p13.3 microdeletions involving the CREB-binding protein gene (CREBBP). We used array-comparative genomic hybridization and Quantitative multiplex fluorescent-PCR (QMF-PCR) to search for dosage anomalies in the 16p13.3 region and the CREBBP gene. We first constructed a microarray covering 2 Mb that carries seven BAC and 34 cosmid clones, as well as 26 low-molecular-weight probes (1000–1500 bp) that are spread along the CREBBP gene. To increase further the resolution inside the CREBBP gene, we used QMF-PCR assays providing a 7 kb resolution. The deletions characterized in this work extended between as little as 3.3 kb and 6.5 Mb. Some deletions were restricted to just a few exons of CREBBP, some deleted either the 5' or the 3' end of the gene plus adjacent genomic segments, others deleted the whole gene away. We also identified a duplication of exon 16. We showed that CREBBP dosage anomalies constitute a common cause of RTS. CREBBP high-resolution gene dosage search is therefore highly recommended for RTS diagnosis. No correlation was found between the type of deletion and the patients' phenotype. All patients had typical RTS, and there was no particular severity associated with certain alterations.

Keywords:

CREBBP gene dosage anomalies, high resolution, Rubinstein–Taybi syndrome

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Smart transcription factors

Nature News and Views (27 Jul 1995)

Extra navigation

.

naturejobs

ADVERTISEMENT